PERINI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.266
EU - Europa 1.819
AS - Asia 1.818
SA - Sud America 408
AF - Africa 401
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 15
Totale 10.759
Nazione #
US - Stati Uniti d'America 6.039
SG - Singapore 612
IT - Italia 442
CN - Cina 414
HK - Hong Kong 348
BR - Brasile 272
FI - Finlandia 204
DE - Germania 181
SE - Svezia 139
PL - Polonia 130
UA - Ucraina 127
FR - Francia 94
GB - Regno Unito 70
RU - Federazione Russa 65
VN - Vietnam 57
NL - Olanda 35
CA - Canada 30
IN - India 28
IE - Irlanda 26
CO - Colombia 22
AT - Austria 20
AR - Argentina 19
MD - Moldavia 19
TR - Turchia 19
CV - Capo Verde 18
MX - Messico 18
TZ - Tanzania 18
BE - Belgio 17
JO - Giordania 17
JP - Giappone 17
DJ - Gibuti 16
KG - Kirghizistan 16
MK - Macedonia 16
MZ - Mozambico 16
PK - Pakistan 16
BA - Bosnia-Erzegovina 15
BO - Bolivia 15
DZ - Algeria 15
EC - Ecuador 15
ID - Indonesia 15
IQ - Iraq 15
IS - Islanda 15
NI - Nicaragua 15
PH - Filippine 15
BD - Bangladesh 14
BF - Burkina Faso 14
BG - Bulgaria 14
GP - Guadalupe 14
RS - Serbia 14
CH - Svizzera 13
KH - Cambogia 13
MA - Marocco 13
MU - Mauritius 13
MY - Malesia 13
PR - Porto Rico 13
SI - Slovenia 13
SO - Somalia 13
ZW - Zimbabwe 13
AO - Angola 12
AZ - Azerbaigian 12
CM - Camerun 12
ES - Italia 12
GF - Guiana Francese 12
LU - Lussemburgo 12
NO - Norvegia 12
PA - Panama 12
PE - Perù 12
PY - Paraguay 12
RE - Reunion 12
UZ - Uzbekistan 12
VC - Saint Vincent e Grenadine 12
VE - Venezuela 12
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
CZ - Repubblica Ceca 11
GR - Grecia 11
HN - Honduras 11
KZ - Kazakistan 11
LB - Libano 11
NE - Niger 11
PT - Portogallo 11
TT - Trinidad e Tobago 11
BW - Botswana 10
BZ - Belize 10
DO - Repubblica Dominicana 10
GA - Gabon 10
IR - Iran 10
JM - Giamaica 10
LV - Lettonia 10
ML - Mali 10
PS - Palestinian Territory 10
RW - Ruanda 10
SA - Arabia Saudita 10
TH - Thailandia 10
AM - Armenia 9
BY - Bielorussia 9
CG - Congo 9
CL - Cile 9
EG - Egitto 9
Totale 10.374
Città #
Woodbridge 625
Fairfield 619
Jacksonville 532
Houston 467
Ann Arbor 466
Chandler 452
Singapore 350
Ashburn 343
Hong Kong 337
Wilmington 303
Santa Clara 285
Cambridge 213
Seattle 204
Princeton 166
Boardman 155
Bytom 104
Beijing 96
San Diego 86
Medford 84
Nanjing 75
Padova 71
Helsinki 63
Munich 49
Roxbury 46
Des Moines 45
Los Angeles 38
Rome 33
Buffalo 31
Shenyang 28
Jiaxing 25
New York 25
Dong Ket 24
Nanchang 24
Turku 24
Dublin 23
Hebei 21
Milan 20
Dar es Salaam 18
Guangzhou 18
São Paulo 17
Brooklyn 16
Amman 15
Bishkek 15
Florence 15
Managua 15
Norwalk 15
Praia 15
Tianjin 15
Djibouti 14
Vienna 14
Changsha 13
Hanoi 13
Harare 13
Hefei 13
Phnom Penh 13
Amsterdam 12
Baku 12
Ouagadougou 12
Redondo Beach 12
Reykjavik 12
Warsaw 12
Chisinau 11
Jinan 11
Kingstown 11
Lima 11
London 11
Luanda 11
Medellín 11
Tashkent 11
Verona 11
Belgrade 10
Cayenne 10
Kigali 10
Kuala Lumpur 10
Libreville 10
Maputo 10
Niamey 10
Redwood City 10
Bamako 9
Belo Horizonte 9
Bologna 9
Brussels 9
Panama City 9
Accra 8
Castries 8
Conakry 8
Istanbul 8
Kharkiv 8
Lusaka 8
Luxembourg 8
Oran 8
Riga 8
Rio de Janeiro 8
Zhengzhou 8
Abidjan 7
Boston 7
Brescia 7
Council Bluffs 7
Dakar 7
Dallas 7
Totale 7.245
Nome #
Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). 344
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression 262
Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26 195
Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. 171
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus 160
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 158
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorder 153
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 149
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report. 148
Hippocampal remodelling after MDMA neurotoxicity: a single case study 142
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS 133
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia 130
The lithium loading dose method in a clinical setting. 130
Life events and alopecia areata. 127
Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: A model for glucocorticoid neural modulation 125
Cognitive and psychiatric evaluation of 40 patients with myotonic dystrophy. 125
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 124
The metyrapone test in manic patients and healthy subjects. 122
Late-onset OCD as presenting manifestation of semantic dementia. 121
Effects of carbamazepine on pituitary-adrenal function in healthy volunteers 121
Research diagnostic criteria (RDC) mental disorder and self-reported symptoms in outpatients with complex partial seizures (CPS). 119
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder 118
Evaluation of linkage signals in a subset of families with high recurrence of schizophrenia and bipolar disorder originating from Chioggia 118
Hypochondriacal fears and beliefs in DSM-III melancholia. Changes with amitriptyline. 116
Hostility and recovery from melancholia. 116
Cognitive disorders and cerebral perfusion abnormalities in SLE 115
Vagus Nerve Stimulation in Treatment-Resistant Depression: A Case Series of Long-Term Follow-up 114
Noradrenergic receptor sensitivity in obsessive compulsive disorder: II. Cortisol response to acute clonidine administration. 113
Aripiprazole in acute mania and long-term treatment of bipolar disorder. A critical review by an Italian Working group 112
Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants 111
Genome scan for schizophrenia/bipolar disorder supports a susceptibility locus in 15q26 111
The metyrapone test in schizophrenic patients and healthy subjects. 110
Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I Growth hormone Response to Clonidine stimulation 109
Paroxetine in alopecia areata 108
Recurrent major depression and Cushing's disease: Project for a volumetric study 107
Depression and anxiety in complex partial seizures. 107
Cognitive Impairment and (CTG)n expansion in myotonic dystrophy patients 107
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age 107
Interictal Mood and Personality Disorders in complex partial epilepsy and Juvenile Myoclonic Epilepsy 104
Heart rate variability parallels changes in psychiatric scales in interferon-treated patients with chronic hepatitis. 104
Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats 103
Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. 103
The cognitive effects of long-term interferon treatment for chronic viral hepatitis 103
Psychoimmunoendocrine aspects of panic disorder 101
The metyrapone test in depressed males. 99
A naturalistic study comparing two initial duloxetine dosing strategies in a clinical "real world" setting 98
Health-related quality of life in Italian patients with systemic lupus erythematosus 96
Rating depression in normals and depressives: observer versus self-rating scales. 96
Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals 96
The metyrapone test in affective disorders and schizophrenia. 96
Multiple perforating lesions and chronic daily headache:a case report 95
Emotions and personality in complex partial seizures. 95
The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment. 95
The dexamethasone suppression and metyrapone tests in depression. 95
Il disturbo bipolare 93
Neurotoxychological Monitoring of Interferon treatment in Viral Hepatitis: a Pilot Sudy 92
Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. 92
IFN treatment in viral Hepatitis really affect mood and cognition? Neuropsychological Changes and Electrophysiological correlates 89
Neurobiologia dell'aggressività  89
Prefrontal dysfunction in cirrhotic patients without overt hepatic encephalopathy decteted by the Stroop Test 86
Intellectual Impairment and cognitiver evoked potentials in myotonic dystrophy 84
CLINICAL OBSERVATIONS ON PANIC DISORDERS 82
Genetic inheritance of schizophrenia and bipolar disorder in an italian population isolate 82
The neurosteroid modulation of normal and pathological anxiety in humans 80
Major depressive disorders and coronary artery disease: a review on common pathophysiological pathways 80
Recurrent Major Depression and Nuclear Magnetic Resonance: A volumetric study, 79
Late-onset affective and psychotic disorders: The challenge of disentangling neurodegenerative diseases from primary psychiatric disorders 79
Psychiatric effects of conventional interferon versus pegilated interferon in chronic hepatitis patients after two and six months of therapy 77
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C 76
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS. 76
Il dolore interiore (o il dolore in psichiatria) 75
Neurophysiological bases of IFN toxicity in the treatment of viral hepatitis: Psychiatric, cognitive changes and long-term electrophysiological correlates. 75
Uso della paroxetina nell'alopecia areata 74
Neurotrofine e RMN Cerebrale nel Disturbo Depressivo Maggiore, 73
Basi neurologiche e aspetti clinici della depressione ricorrente 73
Studio prospettico osservazionale sull'incidenza del disturbo depressivo in pazienti affetti da malattia coronarica acuta e valutazione del decorso del disturbo depressivo 72
Multiple cerebral perforating lesions and chronic daily headache: a case report 71
La qualità  della vita nel lupus eritematoso sistemico. 70
Carbamazepine: A bridge between epilepsy and psychiatric disorders. Premises 69
ESAMI BIOUMORALI E STRUMENTALI IN PSICHIATRIA 68
EFFECTS OF ANTIPSYCHOTIC TREATMENTS ON SERUM PROLACTINE LEVELS. A COMPARATIVE NATURALISTIC STUDY 68
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C. 67
Carbamazepine: a bridge between epilepsy and psychiatry 67
La psicoeducazione nei disturbi bipolari 66
Characterization of a 7% carbon dioxide (C02) inhalation paradigm to evoke anxiety symptoms in healthy subjects 65
Effetti neuropsichiatrici della terapia con interferon: uno studio prospettico di confronto tra PEG-IFN ed IFN α 64
Carbamazepine. A bridge between epilepsy and psychiatric disorders 64
LA BUONA PRATICA PRESCRITTIVA IN PSICOFARMACOLOGIA 63
Effetti neuropsichiatrici dell'uso dell'interferone nel trattamento delle epatiti virali 63
Capitolo 5 Schizofrenia: 63
Capitolo 9: I Disturbi dell'Umore 62
[Affective disorders in general hospitals: the organic affective syndrome]. 62
Stress-responsive neurohormonal systems and the symptom complex of affective illness. 61
Preventing interferon-induced depression in a sample of 44 chronic hepatitis C patients with risk factor for depression 58
Psicosi organiche I: Le psicosi esogene acute o delirium 58
Plasma interleukin-beta and tumor necrosis factor concentrations in obsessive-compulsive disorders 57
Life Charting dei disturbi affettivi ricorrenti: Una guida completa alla valutazione clinica di Leverich GS e Post RM 56
I disturbi mentali organici 56
Depressives syndromes in a general hospita: aetiological analysis of 50 patients referred for consultation 56
Dal blocco del sistema nervoso vegetativo all’ibernazione artificiale: primi risultati di un nuovo indirizzo di terapia psichiatrica. La storia padovana della cloropromazina 54
Totale 10.023
Categoria #
all - tutte 33.490
article - articoli 25.671
book - libri 624
conference - conferenze 0
curatela - curatele 542
other - altro 266
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.450
Totale 65.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021749 0 0 32 99 49 97 33 72 138 51 108 70
2021/20221.182 13 225 110 119 21 91 54 121 37 12 123 256
2022/2023991 235 92 27 98 148 143 13 60 121 11 37 6
2023/2024435 22 69 62 36 19 30 16 20 19 12 60 70
2024/20252.198 17 153 95 93 431 58 85 111 196 81 376 502
2025/20261.929 275 646 1.008 0 0 0 0 0 0 0 0 0
Totale 10.779